Novo CEO pressed by Senate to cut price ranges of being overweight, diabetic issues medicines CEO Lars Fruergaard Jørgensen informed lawmakers the business would think about new talks with insurers concerning the list costs of Wegovy and copyright should they pledge to help keep the medicines on their own formularies. https://dave-s-hot-chicken-nutrit71615.mybjjblog.com/not-known-factual-statements-about-healthcare-news-43857424